News

The open-label, dose-escalation trial will enroll up to 40 patients at multiple centers in the US who have previously been treated with one or two tyrosine kinase inhibitors

POWDER BURN, the first product in the new blaqseries, is the pre-workout available with no banned substances for military personnel which provides energy, mental focus and stamina without

The Phase III trial was designed to compare prasugrel plus aspirin to clopidogrel plus aspirin in the patient population in acute coronary syndrome unstable angina (UA)/ non-ST elevation

The contracts include a two-year application management outsourcing engagement for a university-affiliated children’s hospital and business process re-engineering and application implementation services for a regional health insurer for

The EHR also makes it possible for customers to schedule appointments and supports real-time medical billing. Walgreens senior vice president and chief information officer Tim Theriault said with

The toolkit forms the basis of an Imaging Biomarker Information System (IBIS), which provides computer-assisted diagnosis (CAD) of the lung from CT for early diagnosis, treatment planning and

Solanezumab is a monoclonal antibody being studied as a potential therapy for Alzheimer’s disease. The secondary analysis of the trials data demonstrated slowing of cognitive decline in the

Trastuzumab emtansine uses ImmunoGen’s TAP technology with the trastuzumab antibody and is in global development by Roche under an agreement between ImmunoGen and Genentech, a member of the

The study, which will enroll 44 children from the US, Chile and Mexico, aims to decrease luteinizing hormone (LH) to prepubertal levels at month 6 (Day 169) in